Track Fortis Healthcare Ltd live share price with 52 week high and low, chart views, quick fundamentals, financial highlights, business segments, shareholding pattern, peer comparison, dividends, bonuses/splits and FAQs for customers and retail investors.
Switch between 1 Day, 5 Day, 1 Month and 1 Year chart views. The feed is refreshed with Yahoo Finance-compatible NSE data.
Market data such as price, market cap, valuation ratios, volume and 52 week high/low are pulled from the latest available feed and can differ from NSE/BSE snapshots. Always verify important numbers from official exchange filings before relying on them.
Fortis Healthcare Ltd is an Indian integrated healthcare services company with a focus on hospitals, medical services and diagnostics. Its hospitals provide services across specialties such as cardiac sciences, orthopedics, neurosciences, oncology, gastroenterology, renal sciences, mother and child care, emergency care and critical care.
For customers, the Fortis brand is connected with hospital consultations, admissions, surgeries, medical procedures, diagnostics and care coordination. For investors, the company is usually studied as a healthcare delivery and diagnostics platform where growth depends on bed capacity, occupancy, case mix, pricing, doctor availability, quality of care, acquisitions and operating efficiency.
Beginners should avoid looking only at the share price. A more useful approach is to track hospital occupancy, ARPOB, specialty mix, diagnostics test volumes, EBITDA margin, PAT, net debt, capex and regulatory updates.
Fortis Healthcare is tracked through two broad lenses: hospitals and diagnostics. Hospital performance depends on patient volumes, occupancy, case complexity, pricing and bed maturity. Diagnostics performance depends on test volumes, customer touchpoints, pricing, brand reach and margin stability.
The hospital business is the main revenue contributor and includes inpatient services, outpatient consultations, surgical procedures, emergency services, critical care, specialty programs, sale of medical and non-medical items and management-related income from healthcare facilities.
The diagnostics business, operated through Agilus Diagnostics, includes pathology, radiology and laboratory services. Diagnostics can help Fortis reach patients beyond hospital admissions and can create recurring revenue through tests, preventive health packages and customer touchpoints.
| Segment / driver | FY25 | FY26 | Why it matters |
|---|---|---|---|
| Hospital Business Revenue | ₹6,528 Cr | ₹7,773 Cr | Main revenue engine; growth came with occupied bed expansion and specialty mix. |
| Hospital Operating EBITDA | ₹1,339 Cr | ₹1,724 Cr | Measures operating profit from hospital services before other income. |
| Diagnostics Gross Revenue | ₹1,407 Cr | ₹1,527 Cr | Agilus diagnostics adds testing and customer touchpoints beyond hospitals. |
| Diagnostics Operating EBITDA | ₹249 Cr | ₹360 Cr | Shows profitability and scale benefits in diagnostics. |
| Top specialties | Cardiac, orthopedics, neurosciences, gastroenterology, oncology, renal sciences | Contributed about 62% of hospital revenue | Specialty mix can influence ARPOB, margins and clinical positioning. |
| International patients | ₹539 Cr | ₹639 Cr | Medical value travel can support complex-case revenue but may be sensitive to travel and competition. |
Fortis Healthcare’s financial performance should be read with both consolidated numbers and segment drivers. Revenue growth is useful, but investors should also study EBITDA margin, PAT quality, exceptional items, occupancy, ARPOB and cash conversion.
| Particulars | FY24 | FY25 | FY26 |
|---|---|---|---|
| Consolidated Revenue | ₹6,893 Cr | ₹7,783 Cr | ₹9,128 Cr |
| Operating EBITDA | — | ₹1,588 Cr | ₹2,085 Cr |
| Operating EBITDA Margin | 18.4% | 20.4% | 22.8% |
| Profit After Tax | ₹645 Cr | ₹809 Cr | ₹1,064 Cr |
| Hospital Revenue | ₹5,686 Cr | ₹6,528 Cr | ₹7,773 Cr |
| Diagnostics Revenue | ₹1,207 Cr | ₹1,407 Cr gross / ₹1,255 Cr net | ₹1,527 Cr gross / ₹1,355 Cr net |
| Hospital Occupancy | — | 69% | 68% |
| ARPOB | — | ₹2.42 Cr p.a. | ₹2.51 Cr p.a. |
Financial rows are educational snapshots based on public results and investor material. Verify the latest quarterly and annual numbers from Fortis Healthcare investor relations, NSE and BSE filings.
For a hospital company, the balance sheet matters because hospitals require capital for beds, equipment, buildings, acquisitions and technology. Debt may rise during expansion, and investors should watch whether new capacity improves revenue, EBITDA and return ratios over time.
| Particulars | FY25 | FY26 | What beginners should read |
|---|---|---|---|
| Net Debt | About ₹1,480 Cr implied by reported leverage context | ₹2,334 Cr | Debt rose mainly because of acquisitions and expansion investments. Verify latest figure from filings. |
| Net Debt / EBITDA | 0.93x | 1.09x | Shows how many years of EBITDA may be needed to cover net debt, before interest, tax and other factors. |
| Net Debt / Equity | 0.18x | 0.23x | A lower ratio generally means a lighter balance-sheet debt load, but sector context matters. |
| Hospital capacity investments | Ongoing | Higher investment year | Capacity addition can support growth, but it may take time for new beds to mature. |
| Medical equipment additions | Ongoing | Robots, MRI, Cath labs, PET CT and other equipment added | Technology additions can support complex procedures and specialty revenue. |
Cash flow analysis helps investors see whether accounting profits are being converted into cash after working capital, capex and acquisitions. In healthcare services, capex and equipment purchases can be high, so free cash flow should be viewed across several years rather than one quarter.
| Area | Investor interpretation | Monitorable |
|---|---|---|
| Operating cash flow | A healthcare provider should ideally convert hospital and diagnostics earnings into cash over time. | Compare cash from operations with EBITDA and PAT in the latest annual report. |
| Capital expenditure | Hospitals need regular spending on beds, equipment, technology, maintenance and new facilities. | Track capex, capacity additions, payback period and occupancy ramp-up. |
| Acquisitions | Fortis has used acquisitions to expand network reach and capacity. | Check whether acquired hospitals improve revenue, EBITDA and return ratios after integration. |
| Debt service | Expansion may increase debt before new assets fully contribute. | Track net debt, interest cost, leverage and free cash flow. |
| Diagnostics network | Diagnostics can add asset-light touchpoints and recurring test volumes. | Track Agilus revenue, EBITDA margin, test volumes and customer touch points. |
Ratios help beginners compare performance across time and against peers. For Fortis Healthcare, hospital EBITDA margin, diagnostics margin, occupancy, ARPOB and leverage are especially useful because they connect business operations with financial performance.
| Metric | FY25 | FY26 | How to read it |
|---|---|---|---|
| Operating EBITDA Margin | 20.4% | 22.8% | Higher margin can indicate better operating leverage and specialty mix. |
| Hospital EBITDA Margin | 20.5% | 22.2% | Shows profitability of the hospital delivery business. |
| Diagnostics EBITDA Margin | 17.7% | 23.6% | Shows profitability of Agilus Diagnostics on gross revenue basis. |
| Hospital Occupancy | 69% | 68% | Occupancy shows bed usage; higher occupancy can support operating leverage. |
| ARPOB | ₹2.42 Cr p.a. | ₹2.51 Cr p.a. | Measures average revenue per occupied bed on an annualized basis. |
| Net Debt / EBITDA | 0.93x | 1.09x | Debt monitorable after acquisitions and expansion spending. |
Peer comparison should not be limited to P/E or market cap. Hospital companies can differ in maturity of beds, location mix, specialty focus, international patient revenue, diagnostics exposure, debt, capex cycle and margin profile.
| Company | Yahoo symbol | Business focus | How to compare |
|---|---|---|---|
| Fortis Healthcare Ltd | FORTIS.NS | Hospitals and diagnostics | Compare hospital occupancy, ARPOB, margins, diagnostics growth and leverage. |
| Apollo Hospitals Enterprise Ltd | APOLLOHOSP.NS | Hospitals, pharmacies, digital health and diagnostics | Large diversified healthcare platform with multiple business lines. |
| Max Healthcare Institute Ltd | MAXHEALTH.NS | Hospital network and healthcare services | Compare mature hospital margins, capacity expansion and premium-market exposure. |
| Narayana Hrudayalaya Ltd | NH.NS | Hospitals with strong cardiac and multi-specialty care | Compare cost structure, occupancy, international business and return ratios. |
| Krishna Institute of Medical Sciences Ltd | KIMS.NS | Regional hospital network | Compare regional expansion, bed maturity and profitability. |
| Global Health Ltd | GLOBALHEALTH.NS | Medanta hospital network | Compare premium hospital positioning, ARPOB and expansion pipeline. |
| Year | Dividend Detail | Note |
|---|---|---|
| FY26 | Board recommended final dividend of ₹1 per share, subject to shareholder approval | Verify record date, ex-date and eligibility from NSE/BSE/company filings. |
| FY25 | Dividend information should be checked from official filings | Do not rely on stale dividend tables; payout can change every year. |
| FY24 | Dividend information should be checked from official filings | Check company annual report and exchange corporate action notices. |
| Action | Detail | Note |
|---|---|---|
| Bonus Issue | No current bonus assumption added on this page | Verify from NSE/BSE corporate action filings before relying on bonus history. |
| Stock Split | No current split assumption added on this page | Verify face value and split history from official exchange filings. |
| Face Value | Typically shown in exchange quote data | Confirm latest face value from NSE/BSE because corporate actions can change it. |
Always verify dividend, bonus, split, record date, ex-date, face value and shareholder eligibility from official NSE, BSE and company filings. Corporate action information can change after publication.
These FAQs answer common AI-search-style questions about Fortis Healthcare’s services, business model, share price, risks, dividends, peers and investor monitorables.
Fortis Healthcare Ltd is an integrated healthcare services company. It operates hospitals and related healthcare delivery services and also has a diagnostics business through Agilus Diagnostics. For customers, Fortis is known for multi-specialty hospital care, consultations, surgeries, diagnostics and patient services across several Indian cities.
Fortis Healthcare trades on NSE under the symbol FORTIS and on BSE under the code 532843. This page uses the Yahoo Finance-compatible NSE symbol FORTIS.NS for the live quote and chart feed.
Fortis earns revenue mainly from hospital services such as inpatient care, outpatient consultations, procedures, surgeries, room charges, medical services and related sales. It also earns from diagnostics services, including pathology and radiology tests, through its diagnostics network.
The main business segments are healthcare delivery and diagnostics. Healthcare delivery includes hospitals and medical services. Diagnostics includes laboratory, pathology, radiology and patient test services. Investors should monitor the segment mix, margins and growth separately because hospitals and diagnostics have different operating drivers.
Fortis Healthcare is primarily viewed as a hospital and healthcare services company, but diagnostics is also an important part of the business through Agilus Diagnostics. The hospital business contributes the larger share of revenue, while diagnostics can add scale, recurring test volumes and network reach.
Retail investors commonly track revenue growth, occupancy, ARPOB, average length of stay, bed additions, procedure mix, hospital EBITDA margin, diagnostics test volumes, diagnostics margin, net debt, cash flow, return ratios and any acquisitions or capacity expansion plans.
ARPOB means average revenue per occupied bed. It helps investors understand how much annualized revenue the hospital business generates per occupied bed. It can move because of pricing, specialty mix, complex procedures, payer mix, occupancy and location mix.
Important risks include regulatory changes, pricing controls, doctor and clinical talent availability, medical quality issues, litigation, occupancy fluctuations, payer mix, competition, acquisition integration, debt-funded expansion, diagnostics competition and changes in healthcare demand.
Fortis Healthcare has paid dividends in recent years, but dividend amounts, record dates and shareholder eligibility can change. Investors should always verify the latest dividend announcement from NSE, BSE and the company’s investor relations filings before relying on any dividend information.
This page does not assume any current bonus or stock split unless confirmed by exchange filings. Bonus, split and face value changes should be verified from NSE, BSE and official company announcements before making any investment or tax decision.
Beginners can use the chart to observe recent price movement across 1 day, 5 day, 1 month and 1 year views. The chart is useful for context, but it should not be the only basis for decisions. Price movement should be studied with results, valuation, margins, debt, cash flow and sector trends.
Common listed peers include hospital and healthcare service companies such as Apollo Hospitals, Max Healthcare, Narayana Hrudayalaya, Global Health and Krishna Institute of Medical Sciences. Peer comparison should consider business mix, hospital maturity, bed capacity, occupancy, margin and valuation.
No. This page is for educational and informational use only. It explains share price, fundamentals, business model, financial highlights and monitorables. Investors should do their own research or consult a qualified financial advisor before making decisions.
The latest financial results, shareholding pattern, dividend announcements, bonus or split updates and corporate actions should be verified from NSE, BSE and Fortis Healthcare investor relations filings because these items can change after this page is published.
